You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Aldehyde Dehydrogenase

Showing 26 - 50 of 281
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes in Obese, Obesity, Type2Diabetes Trial in San Diego (SPI-62, Cortisone-d8)

Completed
  • Type 2 Diabetes Mellitus in Obese
  • +2 more
  • Chula Vista, California
    ProSciento
Jan 26, 2023

Inherited Retinal Dystrophy Primarily Involving Sensory Retina Trial (Disulfiram 250 mg, Placebo)

Not yet recruiting
  • Inherited Retinal Dystrophy Primarily Involving Sensory Retina
  • Disulfiram 250 mg
  • Placebo
  • (no location specified)
Nov 22, 2022

Astrocytoma Trial (Vorasidenib, Pembrolizumab)

Not yet recruiting
  • Astrocytoma
  • (no location specified)
Aug 1, 2022

Melanoma Trial in Beijing (tunlametinib, paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin)

Not yet recruiting
  • Melanoma
  • tunlametinib
  • paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 15, 2023

Medium-chain Acyl-CoA Dehydrogenase Deficiency Trial in Pittsburgh (Triheptanoin)

Recruiting
  • Medium-chain Acyl-CoA Dehydrogenase Deficiency
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Sep 27, 2023

Melanoma (Skin), Skin Cancer, Skin Melanoma Trial in Tampa (Vemurafenib, Cobimetinib)

Recruiting
  • Melanoma (Skin)
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Dec 30, 2022

Lactate Blood Increase, Thiamine Deficiency Trial in Charleroi (Thiamine 500 MG, Placebo)

Completed
  • Lactate Blood Increase
  • Thiamine Deficiency
  • Thiamine 500 MG
  • Placebo
  • Charleroi, Hainaut, Belgium
    CHU-Charleroi Hopital Civil Marie Curie
Nov 16, 2022

Recurrent High Grade Glioma Trial (MVR-C5252)

Not yet recruiting
  • Recurrent High Grade Glioma
  • MVR-C5252
  • (no location specified)
Nov 6, 2023

Medium-chain Acyl-CoA Dehydrogenase Deficiency Trial in Pittsburgh (Sodium phenylbutyrate)

Recruiting
  • Medium-chain Acyl-CoA Dehydrogenase Deficiency
  • Sodium phenylbutyrate
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Oct 4, 2023

International Study of Inflammation in COVID-19

Recruiting
  • Covid19
  • +4 more
  • SuPAR, C-reactive protein, Ferritin, D-Dimer, Procalcitonin, Interleukin-6, Lactate Dehydrogenase
  • Ann Arbor, Michigan
    University of Michigan
Aug 17, 2022

Breast Cancer Trial in United States (Reparixin)

Terminated
Has Results
  • Breast Cancer
  • Indianapolis, Indiana
  • +8 more
Apr 15, 2021

Sickle Cell Disease Without Crisis Trial in Chapel Hill (G6PD Deficient Red Blood Cell Transfusion, Non-G6PD deficient Red Blood

Recruiting
  • Sickle Cell Disease Without Crisis
  • G6PD Deficient Red Blood Cell Transfusion
  • Non-G6PD deficient Red Blood Cell Transfusion
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill
Aug 15, 2022

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype Trial in Calgary (Niacin CRT)

Recruiting
  • Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
  • Niacin CRT
  • Calgary, Alberta, Canada
    Tom Baker Cancer Centre
Jul 18, 2022

Vivax Malaria, G6PD Deficiency Trial in Hanura, Labuhanbatu, Mimika (Revised case management package)

Not yet recruiting
  • Vivax Malaria
  • G6PD Deficiency
  • Revised case management package
  • Hanura, Lampung, Indonesia
  • +5 more
May 18, 2023

Leukemia, Myeloid, Isocitrate Dehydrogenase Trial in Worldwide (AG-221, BSC, Azacitidine)

Active, not recruiting
  • Leukemia, Myeloid
  • Isocitrate Dehydrogenase
  • Los Angeles, California
  • +145 more
Jun 7, 2022

Leukemia, Myeloid, Acute Trial in Worldwide (AG-120, Azacitidine, AG-221)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Duarte, California
  • +72 more
Aug 18, 2022

Clinical Development of MR Spectroscopy and Imaging in Brain

Completed
  • Malignant Gliomas
  • +2 more
  • 3 Tesla Scanning
  • 7 Tesla Scanning
  • Dallas, Texas
    UT Southwestern Medical Center
Jan 19, 2022

Recurrent Acute Myeloid Leukemia Trial in Duarte (Bosutinib Monohydrate, Decitabine, Enasidenib Mesylate)

Withdrawn
  • Recurrent Acute Myeloid Leukemia
  • Bosutinib Monohydrate
  • +6 more
  • Duarte, California
    City of Hope Meidcal Center
Jun 7, 2022

Glioblastoma, Diffuse Glioma Trial in Worldwide (NMS-03305293 + TMZ, Lomustine)

Recruiting
  • Glioblastoma
  • Diffuse Glioma
  • Rochester, Minnesota
  • +3 more
Mar 11, 2022

Malaria, Malaria, Vivax, Malaria,Falciparum Trial in Malakheti, Tikapur (primaquine)

Recruiting
  • Malaria
  • +2 more
  • Malakheti, Nepal
  • +1 more
Apr 27, 2022

MDS, Acute Myeloid Leukemia Trial in New Haven (AG-120, Nivolumab)

Withdrawn
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • New Haven, Connecticut
    Yale Cancer Center
Jan 6, 2022

Lactate Kinetics asPredictor of Survival in ACLF With Septic

Not yet recruiting
  • Acute on Chronic Liver Failure
  • No intervention
  • New Delhi, Delhi, India
    Institute of Liver & Biliary Sciences (ILBS)
Nov 2, 2023

Advanced Solid Tumor, Platinum-Resistant Ovarian Cancer, Platinum-Resistant Urothelial Carcinoma Trial in Darlinghurst, Kogarah,

Terminated
  • Advanced Solid Tumor
  • +3 more
  • Darlinghurst, New South Wales, Australia
  • +1 more
Dec 18, 2022

Pyruvate Dehydrogenase Complex Deficiency Trial in Napoli (sodium phenylbutyrate)

Completed
  • Pyruvate Dehydrogenase Complex Deficiency
  • sodium phenylbutyrate
  • Napoli, Italy
    Federico II University
Oct 5, 2021

Cholangiocarcinoma Non-resectable, Cholangiocarcinoma Metastatic Trial (Ivosidenib)

Not yet recruiting
  • Cholangiocarcinoma Non-resectable
  • Cholangiocarcinoma Metastatic
  • (no location specified)
Oct 10, 2023